Right ventricular apical pacing: A necessary evil?

Current Opinion in Cardiology

Volumn 22, Issue 1, 2007, Pages 33-38

  Healey, Jeff S ^a   Yee, Raymond ^b   Tang, Anthony ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Atrial fibrillation; Heart failure; Pacing; Ventricular dyssynchrony

Indexed keywords

ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART VENTRICLE PACING; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SINUS NODE DYSFUNCTION; TREATMENT INDICATION;

ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; CEREBROVASCULAR ACCIDENT; DEFIBRILLATORS, IMPLANTABLE; PACEMAKER, ARTIFICIAL; RISK FACTORS;

EID: 33845462446     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32801177f2     Document Type: Review

References (27)

1. Zoll PM, Linenthal AJ, Norman LR, et al. Use of external electric pacemaker in cardiac arrest. JAMA 1955; 159:1428-1431.
2. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005; 353:145-155.
3. Lamas GA, Lee KL, Sweeny MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-1862.
4. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000; 342:1385-1391.
5. Sweeny MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107:2932-2937.
6. The DAVID Trial Investigators. Dual-Chamber Pacing or Ventricular Backup Pacing in Patients with an Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115-3123.
7. Wilkoff BL. The dual chamber and VVI implantable defibrillator (DAVID) trial: Rationale, design, results, clinical implications and lessons for future trials. Card Electrophysiol Rev 2003; 7:468-472.
8. Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994; 344:1523-1528.
9. Andersen HR, Nielsen JC, Thomsen PEB, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210-1216.
10. Kristensen L, Nielsen JC, Mortensen PT, et al. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart 2004; 90:661-666.
11. Nielsen JC, Kristensen L, Andersen HR, et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 2003; 42:614-623.
12. Sparks PB, Mond HG, Vohra JK, et al. Mechanical remodeling of the left atrium after loss of atrioventricular synchrony. A long-term study in humans. Circulation 1999; 100:1714-1721.
13. Nielsen JC, Pedersen AK, Mortensen PT, et al. Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome. Europace 1999; 2:113-120.
14. Olshansky B, Day J, McGuire M, Pratt T. Inhibition of unnecessary right ventricular pacing with AV search hysteresis in ICDs (INTRINSIC RV). Pacing Clin Electrophysiol 2005; 28:62-66. Study evaluating the minimization of RV apical pacing through programming of existing dual-chamber devices.
15. Is dual chamber programming inferior to single chamber programming in an implantable cardioverter defibrillator? Heart Rhythm Society Annual Scientific Sessions; 17 May 2006; Boston.
16. Anselme F, Savoure A, Defaye P, et al. First clinical results of AAISAFER 2, a new mode to prevent ventricular pacing. Heart Rhythm 2005; 2 (1S):4-99.
17. Savoure A, Frohlig G, Galley D, et al. A new dual-chamber pacing mode to minimize ventricular pacing. PACE 2005; 28 (Suppl 1):S43-S46.
18. Occhetta E, Bortnik M, Magnani A, et al. Prevention of ventricular desynchronization by permanent para-hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: A crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol 2006; 47:1938-1945.
19. Deshmukh P, Cassavant D, et al. Stable electrical performance of high efficiency pacing leads having small surface, steroid-eluting pacing electrodes. PACE 1999; 22:1599-1603.
20. Deshmukh P, Cassavant D, et al. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 2000; 101:869-877.
21. Deshmukh P, Romanyshyn M. Direct His-bundle pacing: present and future. PACE 2004; 27 (6 Pt 2):862-870.
22. Rosenqvist M, Bergfeldt L, et al. The effect of ventricular activation sequence on cardiac performance during pacing. PACE 1996; 19:1279-1286.
23. Mera FD, DeLurgio B, et al. A comparison of ventricular function during high right ventricular septal and apical pacing after His-bundle ablation for refractory atrial fibrillation. PACE 1999; 22:1234-1239.
24. Schwaab B, Frohlig G, et al. Influence of right ventricular stimulation site on left ventricular function in atrial synchronous ventricular pacing. J Am Coll Cardiol 1999; 33:317-323.
25. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA 2003; 289:730-740.
26. Cleland JG, Daubert J-C, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortalilty in heart failure. N Engl J Med 2005; 352:1539-1549.
27. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-Resynchronization Therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.